How Clean Catheterization Can Help MS Patients

Credibility

Interest

Key Takeaway

Using clean intermittent catheterization can significantly help MS patients manage bladder issues.

What They Found

The study looked at 195 MS patients who started using clean intermittent catheterization (CIC) to help empty their bladders. Most of these patients, about 65 out of 100, stuck with the CIC method over a long time, showing that it can be a reliable option. Before starting CIC, many had problems with leaking urine, but after using CIC, fewer patients reported leaks. This means that CIC might help improve bladder control for many MS patients. However, the study also suggests that other factors might have helped reduce leaks, not just the catheterization itself.

Who Should Care and Why

MS patients who struggle with bladder control should be interested because CIC could make their daily life easier and more comfortable. Caregivers will also benefit by understanding how CIC can help their loved ones manage symptoms better. Just like using a tool to fix a leaky faucet, CIC provides a way to manage bladder issues effectively. Knowing about this option can empower patients to take control of their bladder health, leading to fewer accidents and more confidence. Healthcare providers can use this information to support patients in making informed decisions about their care.

Important Considerations

The study didn't explore all the reasons why some patients stopped using CIC, which is important to understand for long-term care. It also focused on a specific group of MS patients, so results may not apply to everyone. These limitations mean that while CIC is helpful, patients should discuss their own situations with their healthcare team to find the best solution for them.

Categories:

Living with MS Specific Symptoms Caregivers

Article Topics:

Adult Neurogenic Lower Urinary Tract DysfunctionCatheterizationDysfonction neurogène du bas appareil urinaireMultiple sclerosisSclérose en plaquesSondage intermittent propre

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like The French journal of urology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News